Japan Respiratory Disease Market Outlook to 2013 Emerging Opportunities

2013-01-24

This report presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies Reviews features and operating characteristics of major analyzers used for microbiology testing; Profiles key suppliers and potential market entrants developing innovative technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.

Request your sample copy @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=68983

Buy Your Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=68983

Table Of Contents

Introduction

Worldwide Market and Technology Overview

A. Major Infectious Disease Tests
1. Adenovirus
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
2. Influenza Viruses
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
3. Legionella
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. Mononucleosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. Mycoplasma
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. Pneumonia
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
7. Respiratory Syncytial Virus (RSV)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. Tuberculosis
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs

B. Instrumentation Review of Leading Analyzers Marketed
by Abbott, Beckman Coulter/Danaher, BioMerieux,
Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,
Wallac and Other Suppliers

C. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other

VI. Japan: Market Size, Growth and Major Suppliers’ Sales and Market Shares

Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Information Technology
D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

Competitive Assessments

List of Tables

Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Tuberculosis Tests Japan
Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Influenza Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Legionella Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Legionella Testing Market Diagnostics Sales Forecast by Major Supplier Japan
Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Mononucleosis Testing Market Diagnostics Sales by Major Supplier Japan
Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Mycoplasma Testing Market Diagnostics Sales by Major Supplier Japan
Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Pneumonia Testing Market Diagnostics Sales by Major Supplier Japan
RSV Test Volume and Diagnostics Sales Forecast by Market Segment Japan
RSV Testing Market Diagnostics Sales by Major Supplier Japan
Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment Japan
Tuberculosis Testing Market Diagnostics Sales by Major Supplier

Filed in: Diagnostics, Medical Device
More Reports
Title Price Buy Now

POCT Market in Europe 2015-2019

POCT is the fastest growing segment of laboratory diagnostics in Europe. It is performed using electronic and non-electronic devices that range from reaction strips to bulky devices. These devices replace a series of laboratory experiments and reduce the turnaround time. POCT diagnostic devices can be categorized into hand-held and near-bedside monitoring devices. The hand-held POCT devices are small, offering mobility while the near-bedside POCT devices are larger and complex. For both the devices, quality control and calibration functionality are checked before performing the tests. The analysts forecast POCT market in Europe to grow at a CAGR of 4.07% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the point......
$2500

Infectious Disease Testing Market in the US 2015-2019

Infectious diseases are caused by microorganisms such as viruses, bacteria, fungi, and parasites. Infectious diseases are one of the primary contributors to morbidity and mortality worldwide. According to the CDC, in the US there are more than 1.2 million people living with HIV infection and one in eight are unaware about their condition. In 2013, it was estimated that 47,352 Americans were diagnosed with HIV infection and in the same year 26,688 people were diagnosed with AIDS. Early diagnosis and treatment play an important role to prevent the long-term complications of HIV/AIDS. Molecular testing, POCT, and immunodiagnostics are used for the screening and detection the disease. Infectious diseases increasingly threaten public health and contribute significantly to the rising costs of he......
$2500

Vitamin D Testing Market in the US 2015-2019

Market outlook of the vitamin D testing market in the US The market research analyst has estimated this market to show steady growth during the forecast period. The prospect for growth in this market is dependent on factors like the high incidence of vitamin D deficiency among the populace in this region, which results in its slow but moderate CAGR of around 4% by 2019. The prevention of various acute and chronic diseases is the key driver for the growth of this market. Vitamin D deficiency can lead to various chronic diseases like rickets and osteoporosis, and can also result in cardiovascular diseases, cancer, asthma in infants, cognitive disorders, and autoimmune diseases. The incidence of these diseases can be reduced by frequently testing the vitamin D levels, which in turn woul......
$2500

Global Immunoprotein Diagnostic Testing Market 2015-2019

Immunoproteins are blood proteins that are used as analytes for different disease diagnostic assays like ELISA, CLIA, immunoturbidity assay, and RIA. The market for immunoprotein diagnostic testing is positively influenced by factors like the growing elderly population and the increased incidence and prevalence of chronic diseases. These factors foster the prospects for growth in this market and results in its healthy CAGR of more than 7% by 2019. Growing focus on early disease diagnosis is the key driver for the growth of this market. Early diagnosis by immunoprotein diagnostic devices helps in disease screening and patient care management during a disease outbreak. Advantages like its ability to reduce the total healthcare expenditure and its ability to reduce the recovery time of pat......
$2500

Vitamin D Testing Market in Europe – Industry Analysis 2015-2019

Vitamin D testing market in Europe at a glance In Europe, approximately 70% of the total population suffers from vitamin D deficiency, of which barely 5-6% has undergone vitamin D testing. This indicates that the vitamin D testing market in Europe is unpenetrated and has a high potential since the market has a large patient pool. Major vendors in Europe understand the potential market scenario and are constantly investing in R&D and innovating vitamin D testing devices, and assays and kits that will provide an accurate result at low cost. Growing vitamin D deficiency will lead to various acute and chronic diseases such as cancer and asthma if not detected at an early stage and can be fatal for a patient. Thus, prevention of these fatal diseases is considered one of the major driv......
$2500

Cancer Testing Market in the US 2015-2019

Cancer Testing Market in the US 2015-2019 Covering: Market size and forecast of the cancer testing market in the US and segmentation by technique, including genetic testing and conventional testing. The report discusses the major drivers influencing market growth and the challenges faced by the vendors and the market as a whole. The top vendors evaluated in the report are Abbott Diagnostics, Agilent Technologies, Beckman Coulter, and Roche Diagnostics. Market outlook of the cancer testing market in the US The market in the US is experiencing a lot of transformation in healthcare coverage, which have led to increased accessibility to healthcare, and thereby facilitating early diagnosis, preventive medicine, and personalized medicine. The increase in genetic testing for cancer by en......
$2500

Global Bone and Mineral Diagnostic Testing Market 2015-2019

Bone and mineral disorders are caused by deficiency of minerals such as calcium, phosphorus, vitamin D, and abnormalities of bone structure or bone mass. Osteoporosis, Paget's disease, and osteogenesis imperfecta are some of the common bone diseases. Bone and mineral diagnostic tests are used for diagnosis and assessment of changes in response to bone disorder therapy. These tests are performed using technologies such as ELISA, CLIA, and RIA. The analysts forecast the global bone and mineral diagnostic testing market to grow at a CAGR of 4.33% over the period 2014-2019. Covered in this Report This report covers the present scenario and growth prospects of the global bone and mineral diagnostic testing market for the period 2015-2019. To calculate the market size, we use revenue ge......
$2500

Global Syphilis Testing Market 2015-2019

Syphilis is a type of sexually transmitted infections disease caused by the bacteria Treponema pallidum subspecies pallidum. The infection spreads mainly through sexual contact. Congenital syphilis, however, affects infants by transmission of the infection from the infected mother to the fetus. The rate of syphilis infection is high among men and particularly in those men who have sex with men. In 2014, around 36 million people worldwide were infected by syphilis. The global burden of syphilis is gradually increasing. Unprotected sex and sexual intercourse with multiple partners, affected by syphilis infection are the key factors contributing to the spread of this infection. However, early diagnosis of the infection enables quick recovery from the disease. Testing methods employed for syph......
$2500

POCT Market in the US 2015-2019

POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients' quality of life. The methods of POCT include meters or monitors and strips. The POCT diagnostic devices are of two types: bedside and near-bedside monitoring devices. The bedside POCT devices are small and offer mobility whereas the near-bedside POCT devices are large and complex......
$2500

Immunodiagnostics Market in China 2016-2020

Immunodiagnostics Market in China 2016-20120 Covering: This market research report includes a detailed segmentation of the immunodiagnostic market in China by technology type (CLIA, ELISA, FIA, MIA, LFIA, and RIA), by product (reagent and instrument), by analyzer type (standalone analyzer and integrated analyzer), and by mode of operation (automated systems, semi-automated systems, and manual systems). The key vendors in this report are Roche Diagnostics, Abbott Diagnostics, Siemens Healthcare Diagnostics, Beckman Coulter, and Sysmex Medical Electronics. Market outlook of the immunodiagnostic market in the China The market research analyst estimates the immunodiagnostics market in China to grow at an impressive CAGR of around 18% by 2020. The introduction of stringent healthcare r......
$3000